Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
HARTE HANKS INC
Bear Case (25th pct.)
-30.3% vs price
Base Case (Median)
-12.6% vs price
Bull Case (75th pct.)
5.4% vs price
◇ = Current price | | Bear | Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| EV/EBITDA | $2.40 | -48.1% | Medium (20%) |
| Earnings Power Value | $5.69 | 23.1% | High (70%) |
Based on 2 out of 7 methods, HHS appears fairly valued at the current price of $4.62. The base case fair value of $4.04 implies 12.6% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.